1. Home
  2. TXG vs BST Comparison

TXG vs BST Comparison

Compare TXG & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • BST
  • Stock Information
  • Founded
  • TXG 2012
  • BST 2014
  • Country
  • TXG United States
  • BST United States
  • Employees
  • TXG N/A
  • BST N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • BST Finance Companies
  • Sector
  • TXG Industrials
  • BST Finance
  • Exchange
  • TXG Nasdaq
  • BST Nasdaq
  • Market Cap
  • TXG 1.3B
  • BST 1.3B
  • IPO Year
  • TXG 2019
  • BST N/A
  • Fundamental
  • Price
  • TXG $14.11
  • BST $38.94
  • Analyst Decision
  • TXG Buy
  • BST
  • Analyst Count
  • TXG 12
  • BST 0
  • Target Price
  • TXG $14.13
  • BST N/A
  • AVG Volume (30 Days)
  • TXG 3.7M
  • BST 99.2K
  • Earning Date
  • TXG 08-07-2025
  • BST 01-01-0001
  • Dividend Yield
  • TXG N/A
  • BST 7.71%
  • EPS Growth
  • TXG N/A
  • BST N/A
  • EPS
  • TXG N/A
  • BST N/A
  • Revenue
  • TXG $624,662,000.00
  • BST N/A
  • Revenue This Year
  • TXG N/A
  • BST N/A
  • Revenue Next Year
  • TXG $5.69
  • BST N/A
  • P/E Ratio
  • TXG N/A
  • BST N/A
  • Revenue Growth
  • TXG N/A
  • BST N/A
  • 52 Week Low
  • TXG $6.78
  • BST $27.87
  • 52 Week High
  • TXG $24.76
  • BST $39.59
  • Technical
  • Relative Strength Index (RSI)
  • TXG 68.91
  • BST 67.07
  • Support Level
  • TXG $11.45
  • BST $38.25
  • Resistance Level
  • TXG $14.16
  • BST $38.85
  • Average True Range (ATR)
  • TXG 0.71
  • BST 0.31
  • MACD
  • TXG 0.08
  • BST -0.03
  • Stochastic Oscillator
  • TXG 93.01
  • BST 98.83

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About BST BlackRock Science and Technology Trust of Beneficial Interest

BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.

Share on Social Networks: